Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • DCseq
    Junior Member
    • Jul 2017
    • 6

    #1

    Pathway analysis and expression counts

    Hi there!

    I am analysing some transcriptomics data with the iPathwayGuide tool on advaitabio.com.
    Turns our that a large number of differentially regulated genes in pathways that come up as significantly different between our test groups has very low expression counts, e.g. average count 15 in group 1, count 5 in group 2 and fold change 3 with significant p value.

    Issue:
    We question any real biological effect of genes with such low expression counts, and also question whether we are able to verify the expression of such genes with molecular biology methods.

    Question:
    We were advised to perform the pathway analysis with an input list that contains all genes, and then set a fold change and p value threshold. Now we are wondering whether we could pre-filter the list of genes (exclude genes with expression count < x) for pathway analysis. Would that be very bad for our statistics? How do people deal with this issue?

    Many thanks for your responses in advance.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:13 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, Yesterday, 10:48 AM
0 responses
18 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...